Kairos Pharma, Ltd.
KAPA
$0.85
-$0.01-1.05%
AMEX
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 5.58M | 3.03M | 3.62M | 1.27M | 3.22M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 24.00K | 88.00K | 55.00K | 38.00K | 10.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 1.06M | 1.72M | 2.38M | 2.86M | 1.52M |
| Total Current Assets | 6.66M | 4.84M | 6.05M | 4.17M | 4.74M |
|
|
|||||
| Total Current Assets | 6.66M | 4.84M | 6.05M | 4.17M | 4.74M |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 102.00K | 142.00K | 182.00K | 222.00K | 262.00K |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1.31M | 1.69M | 1.71M | 1.38M | -- |
| Total Assets | 8.07M | 6.67M | 7.94M | 5.77M | 5.00M |
|
|
|||||
| Total Accounts Payable | 402.00K | 676.00K | 805.00K | 992.00K | 1.53M |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | 142.00K |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 402.00K | 676.00K | 805.00K | 992.00K | 1.67M |
|
|
|||||
| Total Current Liabilities | 402.00K | 676.00K | 805.00K | 992.00K | 1.67M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | 142.00K |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 402.00K | 676.00K | 805.00K | 992.00K | 1.67M |
|
|
|||||
| Common Stock & APIC | 20.56M | 17.50M | 16.73M | 13.59M | 11.17M |
| Retained Earnings | -12.90M | -11.50M | -10.08M | -8.82M | -7.84M |
| Treasury Stock & Other | -- | -- | 484.00K | -- | -- |
| Total Common Equity | 7.66M | 6.00M | 7.13M | 4.78M | 3.33M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 7.66M | 6.00M | 7.13M | 4.78M | 3.33M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 7.66M | 6.00M | 7.13M | 4.78M | 3.33M |
|
|
|||||